Dow Jones

40 211,72

0,53%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:TEVA

<< Précédent 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
06/01/2019	18h45	Business Wire	Teva to Present at the 37th Annual J.P. Morgan Healthcare Conference	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
03/01/2019	02h28	Business Wire	Teva and Amgen Resolve Ongoing Dispute Over Teva’s Generic Cinacalet HCl Product	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/12/2018	18h05	Business Wire	Teva Announces US Launch of a Generic Version of Elidel® (Pimecrolimus) Cream, 1%	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
22/12/2018	17h06	Business Wire	ADDING MULTIMEDIA Teva Announces FDA Approval of First & Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
21/12/2018	22h39	Dow Jones News	FDA Approves Teva's Digital Asthma Inhaler With Built-In Sensors	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
21/12/2018	21h19	Business Wire	Teva Announces FDA Approval of First & Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ (albuterol sulfat...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
18/12/2018	22h09	Dow Jones News	FTC Approves Teva Petition to Give Pfizer More Time to Sell Drug	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
17/12/2018	14h00	Business Wire	Teva Announces Positive Topline Phase IIIb Results with Fremanezumab in Adults with Migraine Who Did Not Respond to Multiple ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
15/12/2018	00h31	Business Wire	Celltrion & Teva Announce FDA Approval of HERZUMA® (trastuzumab-pkrb), a Biosimilar to HERCEPTIN®, for the Treatment of HER...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
14/12/2018	23h57	Dow Jones News	FDA Approves Herceptin Biosimilar Herzuma	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
12/12/2018	16h33	Dow Jones News	FDA Issues Warning Letter to Zhejiang Huahai in Valsartan Recall	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
28/11/2018	21h38	Business Wire	Celltrion & Teva Announce FDA Approval of TRUXIMA® (rituximab-abbs), a Biosimilar to RITUXAN®, for Three Non-Hodgkin’s Ly...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/11/2018	18h08	Dow Jones News	Teva Releases Generic EpiPen in Limited Doses in the U.S. -- Update	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/11/2018	17h02	Dow Jones News	Teva Releases Limited Doses of Generic Version of EpiPen in U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/11/2018	16h06	Business Wire	Teva’s Generic Version of EpiPen® (Epinephrine Injection, USP) Auto-Injector 0.3 mg Now Available in Limited Quantity in ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/11/2018	15h19	Dow Jones News	Teva Shares Rise as Investors Greet Progress in Turnaround	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/11/2018	13h16	Dow Jones News	Teva 3Q Sales Fell 19%	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/11/2018	12h00	Business Wire	Teva Reports Third Quarter 2018 Financial Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
21/10/2018	14h23	Business Wire	Teva and New Jersey Governor Murphy Formalize North America Headquarters Move with Ceremony in Israel	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
12/10/2018	19h30	Dow Jones News	Mylan Gets Favorable Appeals Court Ruling in Patent Dispute Over Teva's Copaxone	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
11/10/2018	11h00	Business Wire	Teva Draws on Patient Experience to Empower Those Living with Chronic Conditions	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
11/10/2018	11h00	Business Wire	Teva nutzt Patientenerfahrungen zur Unterstützung von Patienten mit chronischen Erkrankungen	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
10/10/2018	18h30	Business Wire	Celltrion & Teva Announce FDA Oncologic Drugs Advisory Committee Recommends Approval of Celltrion BLA for CT-P10, a Proposed ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
10/10/2018	17h00	Business Wire	Teva Presents 25-year Safety Data from Longest Continuous Trial of COPAXONE® (glatiramer acetate injection) for the Treatmen...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
08/10/2018	13h00	Business Wire	Teva to Present New Data at 34th European Committee for Treatment and Research in Multiple Sclerosis Congress in Berlin	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
05/10/2018	13h00	Business Wire	Teva to Report Third Quarter 2018 Financial Results on November 1, 2018	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
04/10/2018	08h38	Dow Jones News	Medincell IPO to Raise Up to EUR32.5 Million	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/09/2018	21h49	Dow Jones News	Teva Launches Generic Version of Cialis in the U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/09/2018	21h00	Business Wire	Teva Announces Exclusive First-to-File Launch of a Generic Version of Cialis® in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
20/09/2018	22h14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd